LP-108

Overview

LP-108 is an oral BCL-2 inhibitor being studied for use in several different indications. 

SparkCures ID 676
Generic Name LP-108
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.